An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineTargeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunizationSerum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I moleculesHLA-DR polymorphism affects the interaction with CD4ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsMultiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virusAn epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinAn endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaquesDual neonate vaccine platform against HIV-1 and M. tuberculosis.Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesEvolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.Periodic variation in side-chain polarities of T-cell antigenic peptides correlates with their structure and activityA Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40LConstruction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.Vaccinia virus vectors: new strategies for producing recombinant vaccines.Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c miceImmuno-informatics: Mining genomes for vaccine components.Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routesPlasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGStructural basis of antigen recognition by T lymphocytes. Implications for vaccines.Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis
P2860
Q21092234-BE56C4D4-9318-4ACA-96BF-D726D4CB1A6FQ24670153-EA32612F-68E3-45C9-9143-D745883CC06BQ24675294-50B2BBE1-5460-4E10-B662-F3EB4916CC5CQ24678773-65FE9B2D-C7C5-405A-8BF7-F290C9EDBD2EQ24682788-7880CE9B-2429-4EE1-AA30-963BC292584DQ27480738-3E43AB69-23AE-4C89-ADFF-D132278BEB1DQ27485984-08AE2CCD-B4A1-4D68-942A-673C40197663Q27486239-AF622CA9-AE98-4451-ADB9-F411F33C2A1DQ31019004-3331FDE5-5DB0-4A6D-8509-ACB28349D3FEQ31775839-8F845C61-E2B0-4A67-AA09-787089A5EB70Q32157115-EDDB0370-BA80-49E9-BBDB-FE5324270ED9Q33646310-80E0AD8D-E5C8-48BC-95E0-3F39633DC37BQ33671780-BE233DFD-8E77-4CB5-A30F-241526AA4B07Q33699560-479A1CA5-1CD3-4611-94A6-0E2C42AC96EEQ33784928-58BF04BD-572C-41CD-A66D-A8970DD51CA9Q33788369-C4445486-7A9C-48E2-B1C7-BAFA6CCFC4AEQ33862713-A66381D9-3C25-4DCC-89F9-A9B7A67AC23FQ33877458-CC861AF5-B133-43F1-B1F5-E7C494BFE169Q33908584-32B0C406-B145-460D-836E-E514221E724BQ33916635-8D8AD58E-5DDE-4B51-A2FC-28A7706D67E1Q33927239-FBBC3681-68C2-47CB-823F-D3C6689658B5Q33973345-1A18F796-05B9-450B-83C8-35487291A281Q34098868-A4D7A48F-F347-495A-AAF7-8A9AFB9C48C2Q34191248-DECC44B8-9CB8-4964-8240-006525035D49Q34197974-40506810-5F9C-4CBC-82AE-350091FBDBAEQ34211635-E76D4184-9557-4BE7-B947-742DBEA8E277Q34323839-4D9C619C-0A9A-47D3-BDD5-DC0FAB580977Q34395523-B166CD1A-06B1-4DFB-A172-74E242DBB2F9Q34530656-A5B08B2C-3F89-423D-8F18-522A6F5E20A6Q34592940-04B82A61-F6CF-4592-8D8E-1C21F1A32E9AQ34687622-3238155D-38EE-4912-B972-F85F92CEF471Q34869878-258367F9-4DBF-4BB4-B67D-9613B4068AFFQ34971570-75BC1886-4C3B-4786-B147-AD589780462CQ34983688-6B9D338E-3C85-4DF5-B373-F4F84D316980Q34998726-D1DADF89-8F58-47E6-AB96-EC888502919FQ35028679-58BDCA40-1631-475D-A49D-80C79B170B8DQ35130248-85EF9236-B192-4E0E-BF15-0B80E23E1C0AQ35184235-DD12E286-4080-4798-8F2B-6F9C92FA6B6DQ35593962-FCCE34D0-1CBA-4A9B-BF70-31D864D27928Q35595915-64C9A985-C7BA-4508-9EF6-CBAEE45897A5
P2860
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@ast
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@en
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@nl
type
label
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@ast
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@en
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@nl
prefLabel
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@ast
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@en
An immunodominant epitope of t ...... urine cytotoxic T lymphocytes.
@nl
P2093
P2860
P356
P1476
An immunodominant epitope of t ...... murine cytotoxic T lymphocytes
@en
P2093
H Takahashi
J A Berzofsky
J L Cornette
R Houghten
R N Germain
P2860
P304
P356
10.1073/PNAS.85.9.3105
P407
P577
1988-05-01T00:00:00Z